Related Experiment Video
Updated: Sep 24, 2025

The Use of Mouse Splenocytes to Assess Pathogen-associated Molecular Pattern Influence on Clock Gene Expression
Published on: July 24, 2018
Circadian molecular clock disruption in chronic pulmonary diseases
Allan Giri1, Qixin Wang2, Irfan Rahman2
1Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Circadian clock disruption worsens chronic lung diseases by increasing oxidative stress and inflammation. Understanding these changes could lead to new clock-based therapies.
Area of Science:
- Pulmonary Medicine
- Chronobiology
- Molecular Biology
Background:
- The circadian clock regulates physiological processes in the lung.
- Disruption of this clock is linked to chronic lung diseases.
- Clock disruption exacerbates disease pathology.
Purpose of the Study:
- To review the role of circadian clock disruption in chronic pulmonary diseases.
- To discuss altered clock genes in these conditions.
- To highlight potential for clock-based therapeutic strategies.
Main Methods:
- Literature review of circadian clock disruption in chronic lung diseases.
- Analysis of candidate clock genes affected at transcriptional/translational levels.
- Synthesis of current knowledge on molecular clock mechanisms.
Main Results:
- Circadian clock disruption contributes to oxidative stress, inflammation, metabolic issues, and altered lung function.
- Specific clock genes are altered in chronic pulmonary diseases.
- Evidence links clock dysfunction to disease progression.
Conclusions:
- Circadian clock disruption is a significant factor in chronic lung disease pathogenesis.
- Identifying altered clock genes provides therapeutic targets.
- Further research can advance novel clock-based treatments for lung diseases.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction

